Patent · US Active

Tablet formulation of ezatiostat

US8361971B2 · kind B2 · utility

0Cited by

7References

22Claims

0Family size

Assignee

Telik, Inc. · US

Inventors

Robert T. Lum · Palo Alto, US
Stephan D. Parent · West Lafayette, US
Chunsheng Qiao · Redwood City, US
Steven R. Schow · Washingtonville, US

Key dates

Filing date	Sep 27, 2011
Grant date	Jan 29, 2013
Priority date	—
Expiry date	Sep 27, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are tablets comprising ezatiostat hydrochloride wherein the ezatiostat hydrochloride comprises from about 75 to about 82 percent by weight of the tablet.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.